Technical Analysis for TLSI - TriSalus Life Sciences, Inc.

Grade Last Price % Change Price Change
F 4.01 1.01% 0.04
TLSI closed up 1.01 percent on Friday, November 1, 2024, on 11 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Outside Day Range Expansion 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Spinning Top Other 1.01%
Lower Bollinger Band Walk Weakness 1.01%
Outside Day Range Expansion 1.01%
Gapped Down Weakness 1.01%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 24 hours ago
Possible Inside Day about 24 hours ago
Down 3% 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Cancer Immunotherapy Immunotherapies Pancreatic Cancer Colorectal Cancer Hepatology Hepatocellular Carcinoma Uveal Melanoma Cholangiocarcinoma Intrahepatic Cholangiocarcinoma

Is TLSI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.42
52 Week Low 3.33
Average Volume 46,303
200-Day Moving Average 7.17
50-Day Moving Average 4.54
20-Day Moving Average 4.19
10-Day Moving Average 4.05
Average True Range 0.27
RSI (14) 38.65
ADX 13.04
+DI 13.50
-DI 16.07
Chandelier Exit (Long, 3 ATRs) 4.00
Chandelier Exit (Short, 3 ATRs) 4.64
Upper Bollinger Bands 4.53
Lower Bollinger Band 3.86
Percent B (%b) 0.23
BandWidth 16.10
MACD Line -0.16
MACD Signal Line -0.16
MACD Histogram 0.0018
Fundamentals Value
Market Cap 105.92 Million
Num Shares 26.4 Million
EPS -1.99
Price-to-Earnings (P/E) Ratio -2.02
Price-to-Sales 16.03
Price-to-Book 29.91
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.39
Resistance 3 (R3) 4.37 4.23 4.33
Resistance 2 (R2) 4.23 4.13 4.24 4.31
Resistance 1 (R1) 4.12 4.07 4.17 4.14 4.28
Pivot Point 3.97 3.97 4.00 3.98 3.97
Support 1 (S1) 3.86 3.88 3.92 3.88 3.74
Support 2 (S2) 3.72 3.82 3.73 3.71
Support 3 (S3) 3.61 3.72 3.69
Support 4 (S4) 3.63